Despite being a first-line treatment for CHE, nearly 40% of patients treated with TCS had inadequate treatment response or contraindications to TCS.
Skin irritation or inflammation "triggers a resting hair follicle to go into a growth phase," Dr. George Cotsarelis told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback